Mino-Leon D, Reyes-Morales H, Galvan-Plata ME, Ponce-Monter H, Palma-Aquirre JA, Amato D, Figueras A

Language: Spanish
References: 21
Page: 8-14
PDF size: 698.32 Kb.

ABSTRACT

No abstract

REFERENCES

1. 1.He J,Whelton P. Selection of initial antihypertensive drug therapy.Lancet 2000; 356: 1942-3

2. 2.Flack JM,Novikov SV, Ferrario CM.Benefits of adherence to anti-hypertensive drug therapy.Eur Heart J 1996; 17(Suppl A): 16-20.

3. 3.Cohen JS.Adverse drug effects, compliance,and initial doses of antihypertensive drugs recommended by the Joint National Committee vs. the Physicians Desk Reference.Arch Intern Med 2001; 161:880-5

4. 4.Gascón-Cánovas J,Saturno-Hernandéz P,Llor-Esteban B,Saura-Llamas J, Sánchez-Otuño M, Vicente-López I, et al.Evaluación y mejora de la adhesión terapéutica en los pacientes hipertensos.Aten Primaria 2001; 28: 625-19.

5. 5.Piñeiro F,Gil V, Donis M, Orozco D, Pastor R, Merino J.Validez de 6 métodos indirectos para valorar el cumplimiento del tratamiento farmacológico en la hipertensión arterial.Aten Primaria 1997;19: 372-5

6. 6.Rosas PM,Lara EA,Pastelón HG,Velásquez MO,Martínez RJ,Méndez OA,et al Re-encuesta Nacinal de Hipertensión Arterial(RENAHTA):Consolidación Mexicana de los factores de Riesgo Cardiovascular.Cohorte Nacional de Seguimiento.Arch Cardiol Mex 2005; 75: 96-111.

7. 7.Joyanes A,Higueras LM.De León JM, Sanz E.Análisis de las reacciones adversas detectadas en un centro de atención primaria.Aten Primaria 1996; 17; 262-7.

8. 8.Nies AS.Adverse reactions and interactions limiting the use of antihypertensive drugs.Am J Med 1975: 58: 495-503.

9. 9.Karch FE, Lasagna L. Toward the operational identificacion of adverse drug reactions.Clin Pharmacol Ther 1977;21:247-54.

10. 10.Oviedo MA,Espinosa F.Olivares R,Reyes H, Trejo JA.Guía clinica para el diagnóstico y tratamiento de la hipèrtensión arterial.Rev Med IMSS 2003: 41(Sup.):S15-S26.

11. 11.Ruzicka M, Leenen FH.Monotherapy versus combination therapy as first line tratment of uncomplicated arterial hypertension.Drugs 2001;61 943-54.

12. 12.Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure.JAMA 2003;289: 2560-72.

13. 13.Sequeira RP,Jassim KA,Damanhori AH,Mathur VS.Prescribing pattern of antihypertensive drugs by family physicians and general practitioners in the primary care setting in Bahrain.J Eval Clin Pract 2002; 8:407-14.

14. 14.Gasse C,Stieber J, Doring A, Keil U, Hense HW.population trends in antihypertensive drug use: results from the MONICA Augsburg Project 1984 to 1995.J Clin Epidemiol 1999;52: 695-703.

15. 15.Mateo C,Gil A,Sevillano ML,Barutell I.,Lorenzo A, Pérez de Lucas N, el al. Calidad de la prescripción de fármacos antihipertensivos en un área de salud.Aten Primaria 2000; 25:302-7.

16. 16.Materson BJ,Reda DJ,Cushman WC,Massie BM, Freis ED, Kochar MS, et al. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.Single drug therapy for hypertension in men.A comparison of six antihypertensive agents placebo.N Engl J Med 1993; 328:914-21.

17. 17.Dormann H,Criegee- Rieck M, Neubert A, Egger T,Geise A,Krebs s,et al.Lack of awareness of community-acquired adverse drug reactions upon hospital admission.Dimensions and consequences of a dilemma.Drug Saf 2003: 26:353-62.

18. 18.Hasford J,Goettler M, Munter KH, Muller-Oerlinghausen B. Physicians knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions.J Clin Epidemiol 2002; 55: 945-50.

19. 19.Ambrosioni E, Leonetti G, Achille C, Pappelli A, Trimarco B, Zanchetti A.Patterns of hypertensions management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy.J Hypertens 2000; 18:1691-9.

20. 20.Chamontin B,Amar J. Interactions medicamenteuses avec les antihypertenseurs.Thérapie 1995; 50: 221-6.

21. 21.Conlin PR,Moore TJ,Swartz SL,Barr E,Gazdick L, Fletcher C,et al.Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients.Hypertension 2000;36:461-5